| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/14651858.CD007417.PUB2 |
| P8608 | Fatcat ID | release_j6gacryuivhelpimlqahot2rgq |
| P932 | PMC publication ID | 4269154 |
| P698 | PubMed publication ID | 23633342 |
| P2093 | author name string | Satyanarayana S Vedula | |
| Quan Dong Nguyen | |||
| Yasir J Sepah | |||
| Saban Horo | |||
| Smitha Jasper | |||
| Sheeja S John | |||
| P2860 | cites work | Clindamycin therapy of suspected toxoplasmosis retinochoroiditis | Q68055598 |
| [Efficacy of specific chemotherapy in the prevention of recurrences of toxoplasmic chorioretinitis during the 4 years following the treatment] | Q69062401 | ||
| International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease | Q69741243 | ||
| Quadruple therapy for ocular toxoplasmosis | Q70752976 | ||
| Fulminant ocular toxoplasmosis | Q70964380 | ||
| The treatment of toxoplasmic posterior uveitis (chorioretinitis) | Q71090139 | ||
| [Treatment of congenital toxoplasmosis] | Q71122515 | ||
| Short-term effects of the clindamycin-steroid regimen in the treatment of ocular toxoplasmosis | Q71750352 | ||
| Clindamycin and sulphonamides in the treatment of ocular toxoplasmosis | Q71754899 | ||
| [Results of therapy in ocular toxoplasmosis. Comparison of various forms of therapy] | Q72283297 | ||
| [An analysis of the treatment and evolution of 56 cases of ocular toxoplasmosis] | Q72963571 | ||
| How should active toxoplasmic retinochoroiditis be treated? | Q74427557 | ||
| TOXOPLASMIC RETINOCHOROIDITIS: A DOUBLE BLIND THERAPEUTIC STUDY | Q76570718 | ||
| Signs and symptoms of uveitis. I. Anterior uveitis | Q78635229 | ||
| The effect of corticosteroids on experimental ocular toxoplasmosis | Q79031281 | ||
| Standardization of vitreal inflammatory activity in intermediate and posterior uveitis | Q93559746 | ||
| Toxoplasmosis | Q93840811 | ||
| Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints | Q27860640 | ||
| How to identify randomized controlled trials in MEDLINE: ten years on | Q29620317 | ||
| Antibiotics versus control for toxoplasma retinochoroiditis | Q31040352 | ||
| Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis. | Q31918412 | ||
| Therapy of ocular toxoplasmosis | Q33430723 | ||
| The role of serology in active ocular toxoplasmosis. | Q34246182 | ||
| Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology | Q34444726 | ||
| Toxoplasmosis, an overview with emphasis on ocular involvement | Q35014158 | ||
| Manifestations and management of ocular toxoplasmosis | Q35541346 | ||
| Immunopathogenesis of toxoplasmosis | Q35575817 | ||
| Other infections of the choroid and retina. Toxoplasmosis, histoplasmosis, Lyme disease, syphilis, tuberculosis, and ocular toxocariasis | Q35577598 | ||
| Fulminant toxoplasmic retinochoroiditis following intravitreal triamcinolone administration. | Q35919226 | ||
| Up-date on the treatment of ocular toxoplasmosis. | Q36324602 | ||
| Choroidal Neovascularization as a Late Complication of Ocular Toxoplasmosis | Q36589645 | ||
| Central Nervous System Opportunistic Infections in HIV-1 Infection | Q37085512 | ||
| Treatment of active toxoplasmic retino-choroiditis | Q39747532 | ||
| Steroid therapy in uveitis. | Q39889757 | ||
| Results of treatment of ocular toxoplasmosis with injectable corticosteroids | Q41510040 | ||
| Treatment of toxoplasmosis. The treatment of toxoplasmic chorioretinitis | Q41865155 | ||
| Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis | Q42144107 | ||
| The treatment of toxoplasmic uveitis | Q43210967 | ||
| A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis | Q44049062 | ||
| An update on current practices in the management of ocular toxoplasmosis | Q44049081 | ||
| Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination | Q46232512 | ||
| Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications | Q46577992 | ||
| Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis | Q46711020 | ||
| Survey of ophthalmologists about ocular toxoplasmosis | Q46856707 | ||
| Recurrent toxoplasmic retinochoroiditis after clindamycin treatment | Q46881080 | ||
| [Alternating corticoid therapy] | Q54180595 | ||
| Presumed toxoplasmic papillitis | Q58397601 | ||
| Possibilities of preventing and combating congenital toxoplasmosis | Q66987877 | ||
| Treatment of toxoplasmosis (author's transl) | Q67423678 | ||
| Editorial: Dangers of steroid treatment in toxoplasmosis. Periocular injections and systemic therapy | Q67437496 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toxoplasmosis | Q154878 |
| P304 | page(s) | CD007417 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Corticosteroids as adjuvant therapy for ocular toxoplasmosis | |
| P478 | volume | 4 |
| Q58553452 | A Perspective on Thiazolidinone Scaffold Development as a New Therapeutic Strategy for Toxoplasmosis |
| Q37711857 | Choroidoretinal granuloma in a young female patient |
| Q38138018 | Clinical features and treatment of ocular toxoplasmosis |
| Q34550100 | Corticosteroids as adjuvant therapy for ocular toxoplasmosis. |
| Q39331472 | Infectious uveitis: An enigma |
| Q47125459 | Rapid resolution of toxoplasma chorioretinitis treatment using quadruple therapy |
Search more.